Administration of oral maintenance chemotherapy for 1 year following definitive chemoradiotherapy may improve the survival of patients with stage N3 nasopharyngeal carcinoma

Administration of oral maintenance chemotherapy for 1 year following definitive chemoradiotherapy may improve the survival of patients with stage N3 nasopharyngeal carcinoma

Objectives: This study aims to evaluate the effectiveness and the optimal maintenance period of oral chemotherapy using S1 following definitive chemoradiotherapy in patients with stage N3 nasopharyngeal carcinoma (N3-NPC). Materials and methods: A retrospective review was performed for N3-NPC treatm...

Full description

Bibliographic Details
Main Authors: Chen, B. (Author), Guo, Q. (Author), Hu, C. (Author), Liang, Q. (Author), Lin, S. (Author), Liu, Y. (Author), Pan, J. (Author), Xu, H. (Author), Xu, Y. (Author), Zong, J. (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2021
Subjects:
adult
aged
antineoplastic agent
Antineoplastic Combined Chemotherapy Protocols
Article
cancer patient
cancer staging
cancer survival
chemoradiotherapy
Chemoradiotherapy
controlled study
disease free survival
Disease-Free Survival
distant metastasis free survival
drug efficacy
fatigue
female
follow up
human
Humans
hyperpigmentation
leukopenia
local recurrence free survival
maintenance chemotherapy
Maintenance chemotherapy
Maintenance Chemotherapy
major clinical study
male
N3
Nasopharyngeal carcinoma
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms
nasopharynx carcinoma
nasopharynx tumor
Neoplasm Recurrence, Local
Optimal duration
overall survival
progression free survival
Retrospective Studies
retrospective study
S-1
survival rate
tumor recurrence
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items